4-(morpholinosulfonyl)-N-(quinolin-8-yl)benzenesulfonamide
S17 Figure S2 . Structure of the fragment from the BISL-1 library with numerical designations.
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2-sulfonamidophenylbenzimidazole library
To a solution of 2-aminophenylbenzimidazole (100 mg, 0.48 mmol, 1 eq.) in pyridine (2 ml) is added the desired sulfonyl chloride (1.04 mmol, 1.5 equiv). The clear solution is heated in the microwave at 130 °C for 3 min (Power = 300W). The solution is then poured into 12 mL of water causing the product to precipitate, which is isolated by filtration, and rinsed with water. If no precipitate is formed, the aqueous phase is extracted twice with dichloromethane. The organic layer is then washed with a solution of 1M HCl, dried with anhydrous magnesium sulfate, and evaporated in vacuo to obtain an oil that solidifies when coevaporated with ether. 
2-(2'-(4-biphenyl)sulfonamidophenyl)benzimidazole

2-(2'-(4-(4-chloro)biphenyl)sulfonamidophenyl)benzimidazole
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Synthesis of Control Compounds
2-(4-trifluoromethylphenyl)sulfonamidomethylpyridine
To a solution of 2-methylaminopyridine (47 µl, 0.46 mmol, 1 equiv) in 1 mL of pyridine in a 10 mL microwave tube was added 4-trifluoromethylphenyl sulfonyl chloride (170 mg, 0.69 mmol, 1.5 equiv). The solution was heated in a microwave reactor at 130 °C for 3 min (Power = 300W) and then poured into 6 mL of water. The precipitate is filtered and rinsed with water to yield a brown solid (85 mg, 58% yield). 
N-(naphthalen-1-yl)-4-(trifluoromethyl)benzenesulfonamide
To a solution of 1-aminonaphthalene (50 mg, 0.35 mmol, 1 equiv) in 1 mL of pyridine in a 10 mL microwave tube was added 4-trifluoromethylphenyl sulfonyl chloride (128 mg, 0.52 mmol, 1.5 equiv). The solution was heated in a microwave reactor at 130 °C for 3 min (Power = 300W) and then poured into 6 mL of water. The precipitate was filtered and rinsed with water and recrystallized from EtOH to yield a pink solid (55 mg, 45% yield). 
8-(4-trifluoromethyl)phenylamidoquinoline
In a dry round bottom flask, 4-trifluoromethylphenyl carboxylic acid (200 mg, 1.05 mmol, 1 equiv) was suspended in dry dichloromethane (4 mL) and dry DMF (3 drops). Oxalyl chloride (183 µl, 2.1 mmol, 2 equiv) was added to the solution dropwise. The solution was stirred at room temperature under a dinitrogen atmosphere for 20 min or until no more starting material appeared on the TLC. The mixture is evaporated in vacuo to remove excess oxalyl chloride and dry dichloromethane was added (4 mL) to the crude mixture.
Triethylamine (440 µl, 3.15 mmol, 3 equiv), was added dropwisse followed by 8-aminoquinoline (136 mg, 0.94 mmol, 0.9 equiv) and the solution was stirred at room temperature under nitrogen atmosphere for 18 h. A solution of 1M HCl was added to the mixture to quench the reaction, the organic layer was separated, dried, and evaporated in vacuo.
The crude product was purified via column chromatography (dichloromethane/hexane 6:4) to yield a white solid (165 mg, 50% yield). 
Preparation of Compounds for Assays
The fragments were initially dissolved in dimethyl sulfoxide (DMSO) at a concentration of 50 mM in a 96-well plate. A 10-fold dilution in DMSO was performed to obtain a plate with 50 µL of each fragment at a concentration of 5 mM. 1 µL of each fragment from the 5 mM plate was plated for assays against each enzyme as described below.
Initial screening against each enzyme was repeated a minimum of three times. IC 50 values of fragment hits were measured by preparing serial dilutions of DMSO stocks to obtain a final concentration of 500 µM, 100 µM, 50 µM, 10 µM, 5 µM, 1 µM, 0.5 µM, 0.1 µM, 0.05 µM and 0.01 µM for each hit in the assay.
MMP Inhibition Assays
The assay was carried out in white NUNC 96-well plates as previously described Suite was used to add hydrogen to all structures. Basic residues such as Arg and Lys are protonated, and acidic residues such as Asp and Glu are deprotonated. According to its normal pK a , the His residues were assumed to be neutral. In all models, except for one histidine residue bound to the zinc located in the structural domain, which is protonated in the epsilon position, all the histidines are protonated in the delta position. For models based on crystal structures containing a mutation, those residues were mutated back to the ones found in the wild type form of the enzymes. Table S1 shows the single energy score obtained from models MMP-3 (1QIA), MMP-8 (2OY4), and MMP-9 (2OVX). Table 1 also reports the energy score, DE ele+vdw , calculated by taking the difference between each MMP system and the MMP-2. As observed in Figure S1 and Figure Since the docking of fragment 43 to MMP-3, MMP-8, and MMP-9 appears to be dependent on the crystal structure used, it may indicate that a specific conformation of the receptor is required for the optimum interaction and formation of the bound complex. Thus, it may also suggest that different dynamical behavior associated with different MMPs may be playing an important role in the observed specificity of fragment 43 [3] . Nevertheless, it is S37 worth mentioning that, the computational results agree, at least qualitatively, with the experimental results presented in this work. Table S2 .
Theoretical phases and amplitudes were calculated from available three dimentional structure are inconsistent with monodentate coordination). Importantly, together with the observed changes in the raw edge spectra, the EXAFS curve fitting analysis ( Table S2 ) clearly indicate that fragment 3 directly interacts with the catalytic zinc ion in MMP-12. 
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